维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Subleski J"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Immunotherapy of cancer by IL-12-based cytokine combinations显示文摘	Weiss J M Subleski J J Wigginton J M	2007	Expert Opin Biol Ther2007，7，11：	1
2	The split personality of NKT cells in malignancy, autoimmune and allergic disorders显示文摘	Subleski J J Jiang Q Weiss J M	2011	Immuno- therapy2011，3，10：	1
3	The proinflammatory cytokine interleukin-18 alters multiple signaling pathways to inhibit natural killer cell death显示文摘	Hodge DL Subleski J J Reynolds DA	2006	J Interferon Cytokine Res2006，26，10：	1
4	Cutting edge:expression of TNFR2 defines a maximally suppressive subset of mouse CID4^+ CD25^+ FoxP3^+ T regulatory cells : applicability to tumor-infiltrating T regulatory cells 显示文摘	Chen X Subleski J J Kopf H	2008	J Immunol2008，180，10：	1
5	Application of tissue specific NK and NKT cell activity for tumor immunotherapy 显示文摘	Subleski J J Wiltrout RH Weiss JM	2009	Autoimmun2009，33，34：	1
6	Expression of costimula tory TNFR2 induces resistance of CD4+ FoxP3 conventional T cells to suppression by CD4+ Foxp3+ regulatory T cells显示文摘	Chen X Hamano R Subleski J J	2010	The Journal of Immunology2010，185，1：	1
7	Application of tissue-specific NK and NKT cell activity for tumor im- munotherapy显示文摘	Subleski J J Wiltrout R H Weiss J M	2009	J Autoimmun2009，33，34：	1
8	Application of tissue specific NK and NKT cell activity for tumor immunotherapy显示文摘	Subleski J J Wihrout R H Weiss J M	2009	Autoimmtm2009，33，34：	1
9	Immunotherapy of cancer by IL-12-based cytokine combinations 显示文摘	Weiss JM Subleski J J Wigginton JM	2007	Expert Opin Biol Ther2007，7，11：	1
10	Cutting Edge:Expression of TNF-R2Defines a Maximally Suppressive Subset of Mouse CD4+CD25+F-oxP3+T Regulatory Cells:Applicability to Tumor-Infilt-rating T Reg-ulatory Cells显示文摘	Chen X Subleski J Kopf H	2008	Immunology2008，180，：	1
11	Co-expression of TNFR2and CD25identifies more of the functional CD4+FOXP3+regulatory T cells in human peripheral blood显示文摘	Chen X Subleski J Hamano R	2010	European Jour nal of Immuno-logy2010，40，4：	1
12	Immunotherapy of cancer by IL- 12- based cytokine combinations显示文摘	Weiss JM Subleski J J Wigginton JM	2007	Expert Opin Biol Ther2007，7，11：	1
13	Application of tissue-specific NK and NKT cell activity for tumor immunotherapy显示文摘	SUBLESKI J J WILTROUT R H WEISS J M	2009	J Autoimmun2009，33，34：	1
14	The proinflammatory cytokine interleukin-18 alters multiple signaling path ways to inhibit natural killer cell death 显示文摘	Hodge D L Subleski J J Reynolds D A	2006	J Interferon Cytokine Res2006，26，10：	1
15	lmmunotherapy of cancer by IL-12-based cytokine combinations 显示文摘	Weiss JM Subleski J J Wigginton JM	2007	Expert Opin Biol Ther2007，7，11：	1
16	Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver显示文摘	Subleski J J Hall VL Back TC	2006	Cancer Res2006，66，22：	1
17	Nitric oxide is a key component in inflammation-accelerated tumorigenesis显示文摘	Hussain SP He P Subleski J	2008	Cancer Res2008，68，17：	1
18	Peroxisome proliferator - activated receptor - 3p and its ligands attenuate biologic functions of human naturial killer cells 显示文摘	ZHANG X RODRIGUEZ - GALAN M C SUBLESKI J J	2004	Blood2004，104，10：	1
19	Application of tissuespecific NK and NKT cell activity for tumor immunothcrapy 显示文摘	Subleski J J Wihrout R H Weiss J M	2009	J Autoimmun2009，33，34：	1
20	Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4 ^+ CD25 ^+ FoxP3^+ T regulatory cells: applicability to tumor-infiltratingT regulatory cells显示文摘	Chen X Subleski J J Kopf H	2008	J Immunol2008，180，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示